Neoadjuvant Nivolumab for Patients with Resectable HPV-positive and HPV-negative Squamous Cell Carcinomas of the Head and Neck in the CheckMate 358 Trial
Journal for ImmunoTherapy of Cancer(2021)
Key words
clinical trials as topic,head and neck neoplasms,immunotherapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined